Literature DB >> 7118846

A case of neuroleptic malignant syndrome successfully treated with amantadine.

M M McCarron, M L Boettger, J J Peck.   

Abstract

A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma. Treatment with diphenhydramine and benztropine mesylate was ineffective. Administration of amantadine HCl resulted in resolution of all symptoms within 24 hours. After 2 days, the amantadine was discontinued. The following day, the neuroleptic malignant syndrome appeared. Readministration of amantadine again resulted in prompt remission of symptoms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118846

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

Review 1.  Acute poisoning: understanding 90% of cases in a nutshell.

Authors:  S L Greene; P I Dargan; A L Jones
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

2.  [Prolonged neuroleptic malignant syndrome after Haloperidol injection].

Authors:  N Wystub; S Heymel; M Fritzenwanger; P C Schulze; R Pfeifer
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-27       Impact factor: 0.840

3.  Amantadine in neuroleptic malignant syndrome.

Authors:  A Jee
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

4.  Neuroleptic malignant syndrome successfully treated with amantidine.

Authors:  J Woo; R Teoh; J Vallance-Owen
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

5.  Recurrence, hyponatraemia and neuroleptic malignant syndrome.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

6.  Anesthetic management of a pediatric patient with neuroleptic malignant syndrome.

Authors:  Tarun Bhalla; Douglas Maxey; Amod Sawardekar; Joseph D Tobias
Journal:  J Anesth       Date:  2011-11-19       Impact factor: 2.078

Review 7.  Adverse effects of antipsychotic drugs.

Authors:  A K Malhotra; R E Litman; D Pickar
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

8.  Neuroleptic malignant syndrome.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02

Review 9.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

10.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.